The GLP-1 Support Category, Explained

GLP-1 receptor agonist medications have reshaped consumer behavior around weight management faster than almost any pharmaceutical development in recent memory, and the supplement industry has responded with an entirely new product category in turn. But "GLP-1 support" has quickly become a catch-all term applied to products with very different mechanisms, evidence bases, and intended use cases.

The following FAQ breaks down what manufacturers actually need to understand before formulating, marketing, or making claims in this space.

What Does GLP-1 Support Actually Mean as a Product Category?

GLP-1 support has come to describe 2 distinct types of products that are often marketed under the same umbrella term. The first category includes supplements designed to address nutrient gaps and side effects associated with GLP-1 receptor agonist medications such as semaglutide and tirzepatide; think protein powders to preserve lean muscle mass, multivitamins to fill micronutrient shortfalls, and probiotics to manage gastrointestinal side effects.

The second category includes ingredients marketed to support the body's own natural GLP-1 production or secretion, independent of pharmaceutical use. These are mechanistically very different propositions, and manufacturers should be precise about which one a given product is making.¹

Why Do People on GLP-1 Medications Need Nutritional Support?

GLP-1 medications work primarily by suppressing appetite and slowing gastric emptying, which leads to substantially reduced food intake. As registered dietitian Tabitha Daley of The Vitamin Shoppe noted in reference to the brand's Whole Health Rx line, this reduced intake creates "specific nutritional challenges" that can be difficult for consumers to navigate on their own.²

Industry experts have pointed to dehydration, early satiety, and appetite suppression as common issues, alongside the more serious concern of muscle mass loss, since rapid weight loss is rarely fat loss alone.¹ Louis Aronne, MD, FACP, who collaborated with youtheory on a doctor-formulated GLP-1 support line, has specifically flagged vitamin B12, vitamin D, iron, and calcium as nutrients commonly depleted during significant GLP-1-driven weight loss.³

Is There Clinical Evidence That Any Supplement Ingredient Actually Increases the Body’s Own GLP-1 Levels?

Some ingredients do have published human research showing measurable effects on GLP-1 secretion, though the body of evidence varies considerably by ingredient. Eriomin, a citrus flavonoid complex from Ingredients by Nature, has been studied in a randomized controlled trial that found significant improvements in glucose, insulin resistance, and a 17% increase in GLP-1 alongside reductions in inflammatory markers.⁴

A more recent 2025 trial found the same ingredient may serve as a beneficial adjunct to metformin in prediabetic patients, improving glucose response after a two-hour oral glucose tolerance test.⁵ Separately, Trpti, a bioavailable form of oleoylethanolamide developed by Saanroo using a lipid delivery system, has been studied in 2 clinical trials showing increased GLP-1 levels alongside decreased levels of DPP-4, the enzyme responsible for degrading GLP-1 in the body.⁶

How Should Manufacturers Think About Protein Formulation for the GLP-1 Support Category?

Muscle mass preservation has emerged as one of the most consistently emphasized formulation priorities across GLP-1 support product launches. ADM's 2025 consumer research found that 83% of GLP-1 medication users expressed interest in customized nutritional solutions, with muscle retention identified as a key priority driving demand for high-protein formats.⁷

Several recent product launches reflect this directly: Danone's Oikos Fusion drink combines whey, leucine, and vitamin D in a low-volume, high-impact format designed for consumers eating less overall, while The Vitamin Shoppe's GLP-1 Support Protein combines 30 g of whey with 5 g of collagen alongside muscle-preservation ingredients myHMB and PeptiStrong.²^,⁸ The through line across these formulations is delivering meaningful protein density in smaller volumes, since GLP-1 users are eating and drinking less overall.

What Should Manufacturers Be Cautious About When Making GLP-1-Related Claims?

The distinction between supporting a GLP-1 user's nutritional needs and claiming to replicate or enhance pharmaceutical GLP-1 activity is a meaningful one from both a scientific and a regulatory perspective.

GLP-1 receptor agonist medications are approved drugs for type 2 diabetes and obesity, and supplements cannot legally claim to treat these conditions or to replace medication. As 1 industry expert has framed it, supplements aimed at healthy populations are meant to offer support around the broader hormonal and metabolic pathway, not to substitute for medical treatment in those who need it.⁹

Manufacturers should ensure that any claims regarding ingredient effects on GLP-1 levels are grounded in ingredient-specific human clinical data, rather than general category momentum.

References

1. Krawiec S. The GLP-1 train: how dietary supplements can aid GLP-1 drug users. Nutritional Outlook. May 15, 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/the-glp-1-train-how-dietary-supplements-can-aid-glp-1-drug-users

2. McEvoy E. Whole Health Rx launches GLP-1 supplement line to counter side effects of the weight loss drugs. Nutritional Outlook. April 1, 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/whole-health-rx-launches-glp-1-supplement-line-to-counter-side-effects-of-the-weight-loss-drugs

3. McEvoy E. Doctor-formulated GLP-1 support supplements launched by wellness brand youtheory. Nutritional Outlook. February 12 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/doctor-formulated-glp-1-support-supplements-launched-by-wellness-brand-youtheory

4. Krawiec S. Supporting GLP-1, naturally. Nutritional Outlook. November 18, 2025. Accessed June 29, 2026.https://www.nutritionaloutlook.com/view/supporting-glp-1-naturally

5. Cesar R, Oliveira MR, Sandrim V, et al. Citrus flavonoid supplement enhances glycemic and metabolic control in prediabetic patients on metformin: a randomized controlled trial. Front Nutr. 2025;12:1639901. doi:10.3389/fnut.2025.1639901

6. Krawiec S, Venkatesh R. Bioavailable OEA for GLP-1 support. Nutritional Outlook. November 21, 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/bioavailable-oea-for-glp-1-support

7. Schwan B, Saraceno N. Tackling reformulation and GLP-1 trends with consumer-driven innovation. Nutritional Outlook. March 23, 2026. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/tackling-reformulation-glp-1-trends-innovation

8. McEvoy E. New cultured dairy drink from Oikos offers nutrition for GLP-1 users to retain muscle. Nutritional Outlook. August 11, 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/new-cultured-dairy-drink-from-oikos-offers-nutrition-for-glp-1-users-to-retain-muscle

9. McEvoy E. GLP-1 and supplements: natural solutions for metabolic health at SupplySide Global 2025. Nutritional Outlook. October 15, 2025. Accessed June 29, 2026. https://www.nutritionaloutlook.com/view/glp-1-and-supplements-natural-solutions-for-metabolic-health-at-supplyside-global-2025